Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2008
12/18/2008CA2683152A1 Substituted pyrazole compounds
12/17/2008EP2003211A2 Process for producing optically active (s)-7-hydroxy-6-methylheptane-2-one and precursor thereof
12/17/2008EP2003207A2 Antisense inhibition of PTP1B expression
12/17/2008EP2003202A2 G protein-coupled receptor up-regulated in prostate cancer and uses thereof
12/17/2008EP2003201A2 Compounds and methods for therapy and diagnosis of lung cancer
12/17/2008EP2003142A1 Amorphous perindopril erbumine
12/17/2008EP2003140A2 Galactose derivative, drug carrier and medicinal composition
12/17/2008EP2003136A1 Process for producing high-purity prasugrel and acid addition salt thereof
12/17/2008EP2003134A2 Hydromorphinone and hydrocodeinone compositions and methods for their synthesis
12/17/2008EP2003132A1 Hetero compound
12/17/2008EP2003131A1 Aminopyrrolidine compound
12/17/2008EP2003130A2 Novel pyridine derivative having anti-helicobacter pylori activity
12/17/2008EP2003122A2 Process for the production of 5-hydroxy-1-methylhydantoin
12/17/2008EP2003120A1 Azapeptide derivatives as HIV protease inhibitors
12/17/2008EP2003119A1 Substituted acetamides as modulators of EP2 receptors
12/17/2008EP2003118A1 Cinnamic acid derivatives as modulators of EP2 receptors
12/17/2008EP2002863A1 [1,10]-phenanthroline derivatives for the treatment of neurodegenerative or haematological diseases
12/17/2008EP2002846A2 Combination therapy using an IL-1 inhibitor for treating IL-1 mediated diseases
12/17/2008EP2002845A2 Combinations comprising antimuscarinic agents and corticosteroids
12/17/2008EP2002844A2 Combinations comprising antimuscarininc agents and beta-adrenergic agonists
12/17/2008EP2002843A2 Combinations comprising antimuscarinic agents and beta-adrenergic agonists
12/17/2008EP2002841A1 Ophthalmic composition comprising xanthan gum and glucose
12/17/2008EP2002840A2 Method for treating oncological diseases
12/17/2008EP2002839A1 Folic acid-containing pharmaceutical compositions, and related methods and delivery systems
12/17/2008EP2002838A1 Use of aryl and hetaryl amide derivatives as modulators of an EP2 receptor
12/17/2008EP2002837A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
12/17/2008EP2002836A1 Cyclocondensed azaindoles active as kinase inhibitors
12/17/2008EP2002835A1 Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
12/17/2008EP2002834A1 Aryl and hetaryl amides as modulators of EP2 receptors
12/17/2008EP2002832A2 Composition containing lignan compound
12/17/2008EP2002831A1 R-Bambuterol, its preparation and therapeutic uses
12/17/2008EP2002830A1 Compositions comprising pantothenic acid or derivatives thereof and their use for stimulating appetite
12/17/2008EP2002828A2 Solid pharmaceutical preparation
12/17/2008EP2002827A2 Methods and compositions for control of bone formation via modulation of sympathetic tone
12/17/2008EP2002826A1 Titratable dosage transdermal delivery system
12/17/2008EP2002825A1 Pharmaceutical compositions comprising orlistat
12/17/2008EP2002731A1 Use of pinolenic acid for increasing lean body mass
12/17/2008EP2002730A1 Pinolenic acid compositions for treating fatty liver
12/17/2008EP2002729A1 Use of pinolenic acid for lowering cholesterol
12/17/2008EP2002018A2 Antisense antiviral compound and method for treating arenavirus infection
12/17/2008EP2002004A2 Small internally segmented interfering rna
12/17/2008EP2001897A2 Compounds and methods for treatment of disorders associated with er stress
12/17/2008EP2001894A1 Novel bis-2-difluoro-pyrroloý2,1-c¨ý1,4¨benzodiazepine dimmers
12/17/2008EP2001893A2 Thiadiazole compounds and their use in phototherapy
12/17/2008EP2001891A1 Buprenorphine derivatives and uses thereof
12/17/2008EP2001887A1 Pyrrolo-quinoxalinone derivatives as antibacterials
12/17/2008EP2001886A2 Pyrrolotriazine aniline prodrug compounds useful as kinase inhibitors
12/17/2008EP2001885A2 Octahydro-pyrrolo[3,4-b]pyrrole derivatives
12/17/2008EP2001882A1 Substituted indazole derivatives, their manufacture and use as pharmaceutical agents
12/17/2008EP2001881A2 Compositions and methods for treating respiratory disorders
12/17/2008EP2001880A2 Heterobicyclic pyrazole compounds and methods of use
12/17/2008EP2001879A1 Azolopyridin-3-one derivatives as inhibitors of endothelial lipase
12/17/2008EP2001878A1 Imidazopyridin-2-one derivatives as inhibitors of endothelial lipase
12/17/2008EP2001875A2 Glucokinase activators
12/17/2008EP2001872A1 Benzofuran compounds as ep1 receptor antagonists
12/17/2008EP2001870A2 Kinase inhibitors
12/17/2008EP2001868A1 Inhibitors of the interaction between mdm2 and p53
12/17/2008EP2001866A2 Organic compounds
12/17/2008EP2001865A1 Sulfonyl-3-heterocyclylindazole derivatives as 5-hydroxytryptamine-6 ligands
12/17/2008EP2001864A1 Heterocyclic organic compounds for the treatment of in particular melanoma
12/17/2008EP2001863A1 2-(cyclic amino)-pyrimidone derivatives as tpk1 inhibitors
12/17/2008EP2001862A2 Malate salts, and polymorphs of (3s,5s)-7-ý3-amino-5-methyl-piperidinyl¨-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid
12/17/2008EP2001857A2 Photoactive compounds and compositions and uses thereof
12/17/2008EP2001856A1 Crystalline forms of n- {2-tert -butyl -1- [ (4,4- dif luorocyclohexyl) methyl]-lh-benzimidazol-5- yl}ethanesulfonamide salts
12/17/2008EP2001851A2 Amide derivatives and their application for the treament of g protein related diseases
12/17/2008EP2001849A1 Pyridine and pyrimidine derivatives as mglur2 antagonists
12/17/2008EP2001848A1 Piperidines and related compounds for the treatment of dementia
12/17/2008EP2001846A1 Indole derivatives as inhibitors of the soluble adenylate cyclase
12/17/2008EP2001844A2 Bicyclic carboxylic acid derivatives useful for treating metabolic disorders
12/17/2008EP2001843A2 Soluble adenylate cyclase inhibitors
12/17/2008EP2001842A2 2-methylene-1alpha-hydroxy-19,21-dinorvitamin d3 analogs and uses thereof
12/17/2008EP2001841A2 2-methylene-1 alpha-hydroxy-18,19,21-trinorvitamin d3 analogs and uses thereof
12/17/2008EP2001840A1 Associations of xanthogenates and cyclodextrins, and their use
12/17/2008EP2001838A2 Selective hydroxamate based mmp inhibitors
12/17/2008EP2001833A1 Anti-diabetic cataract compounds and their uses
12/17/2008EP2001832A1 Methods and compositions for making and using polymorphs of cinacalcet
12/17/2008EP2001831A2 Compounds which inhibit the glycine transporter and uses thereof
12/17/2008EP2001556A1 Thioninium compounds and their use
12/17/2008EP2001555A1 Use of strobilurins for treating malfunctions of the iron metabolism
12/17/2008EP2001521A2 Stabilized, sterilized collagen scaffolds with active adjuncts attached
12/17/2008EP2001512A2 Use of the staudinger ligation in in vivo assembly of a biologically active compound
12/17/2008EP2001500A2 Formulations for ecallantide
12/17/2008EP2001497A2 Pharmaceutical compositions
12/17/2008EP2001495A2 Methods for regulating neurotransmitter systems by inducing counteradaptations
12/17/2008EP2001492A1 A method of treating cancer and/or cellular proliferative conditions and agents targeting hyaluronan anabolism useful for same
12/17/2008EP2001491A1 Anti-allergy compositions
12/17/2008EP2001490A1 Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement
12/17/2008EP2001489A2 Pharmaceutical compositions for promoting wound healing
12/17/2008EP2001488A2 Prevention and treatment of cancer and other diseases
12/17/2008EP2001487A2 Fluorinated carbohydrates and their use in tumor visualization, tissue engineering, and cancer chemotherapy
12/17/2008EP2001486A2 Bisphosphonate compounds and methods
12/17/2008EP2001485A2 Diazepan orexin receptor antagonists
12/17/2008EP2001484A2 Methods and compositions for treating hypercholesterolemia and atherosclerosis
12/17/2008EP2001483A1 Use of cholest-4-in-3-in-one derivatives to obtain a cytoprotective medicine
12/17/2008EP2001482A2 Disease modifying anti-arthritic activity of 2-methoxyestradiol
12/17/2008EP2001481A2 Aprepitant polymorph mixtures
12/17/2008EP2001480A2 Indazole compounds
12/17/2008EP2001479A2 Co-administration of adenosine a1 receptor antagonists and anticonvulsants
12/17/2008EP2001478A1 Cyclohexyl or piperidinyl carboxamide antibiotic derivatives
12/17/2008EP2001477A2 Paclitaxel combination
1 ... 2949 2950 2951 2952 2953 2954 2955 2956 2957 2958 2959 2960 2961 2962 2963 2964 2965 2966 2967 2968 2969 ... 7860